AUCTUS Capital Partners
With more than 90 transactions realised since 2001, AUCTUS has established itself as the leading private equity firm for the German-speaking SME sector (“Mittelstand“). We seek majority interests in companies, e.g. in succession and corporate spin-off situations, and pursue roll-up/buy and build strategies.
Based on the Latin word “AUCTUS”, our company name represents our entrepreneurial mind-set focusing on “sustainable growth”. Together with management teams, we strive to increase the value of a company by achieving sales and earnings growth.
AUCTUS is a partnership of entrepreneurs.
What we do
|You would like to remain a shareholder while diversifying your personal assets|
|You are looking to plan the succession of your company and turn your attention to other interests|
|Selling your business|
|You would like to acquire competitors and generate more growth|
|The owners of your business are looking to sell their shares and you as a manager aim to acquire them|
- AUCTUS among Top 10 best Buy-Out Funds in the world for the fourth consecutive time
- Further on growth track: AUCTUS portfolio company PharmaLex acquires Lindeq AS
- AUCTUS again best Buy-Out Fund
- AUCTUS portfolio company YES Pharma Services and PharmaLex are merging
- AUCTUS portfolio company YES Pharma Services enters the UK Pharma market with the acquisition of WAINWRIGHT Associates
Industry: Health Care
Transaction type: Management Buy-Out (MBO) / Buy & Build
Sales: 10-20 m€